Engineered for precise coefficient of friction reduction, inert biological compatibility, and superior coating integrity across clinical interfaces.
Polydimethylsiloxane (PDMS), commonly known as dimethicone or medical silicone fluid, represents the gold standard in biomedical lubrication and surface functionalization. As healthcare delivery transitions toward self-administration parenterals, ultra-fine micro-cannulas, and minimally invasive surgical robotics, the tribological performance of device-tissue and device-device interfaces has become a vital engineering metric. Medical-grade PDMS silicone oil provides an unmatched combination of ultra-low surface tension, chemical inertness, optical transparency, thermal resilience, and physiological biocompatibility conforming to strict ISO 10993 and USP Class VI toxicological profiles.
In global parenteral packaging and medical consumable manufacturing, silicone oil acts as a performance-enabling coating. The worldwide market for medical silicone fluids is witnessing continuous expansion driven by the exponential growth of biological drugs (mAbs, recombinant proteins, GLP-1 agonists), pre-filled syringe (PFS) platforms, single-use needle devices, and intravenous catheterization lines. Manufacturers require lubricants that eliminate erratic dynamic friction, preserve tactile feedback for surgeons, and minimize patient insertion discomfort while guaranteeing zero extractable degradation under rigorous sterilization modalities.
PDMS polymers possess a highly flexible siloxane backbone (Si-O-Si bond angle of 143°), allowing non-polar methyl side groups to align at interfaces, drastically suppressing static break-loose force (Fsb) and gliding force (Fsg).
Exhibits exceptional molecular integrity during Ethylene Oxide (EtO), Gamma Radiation (25-40 kGy), Electron-beam (E-beam), and Autoclave steam sterilization, maintaining viscosity and chemical stability without yellowing.
Manufactured with controlled cyclosiloxane (D4/D5/D6) residuals and non-detectable heavy metal catalysts to prevent protein aggregation, sub-visible particle formation, and leachables in sensitive biopharmaceuticals.
The primary mechanical objective in pre-filled syringe assemblies is establishing a smooth, predictable force displacement curve during plunger actuation. Untreated glass or cyclic olefin polymer (COP/COC) syringe barrels create high friction against bromobutyl or chlorobutyl elastomeric stoppers, resulting in stick-slip phenomena, plunger jamming, or dosage delivery inaccuracies. Applying a micro-thin layer (typically 0.1 to 1.0 mg per barrel) of medical-grade polydimethylsiloxane oil (350 cSt to 12,500 cSt) establishes a continuous hydrodynamic boundary film.
This siliconization stabilizes the initial break-loose force (preventing high initial thumb resistance for patients) and delivers continuous smooth extrusion. Furthermore, modern auto-injectors rely on precise spring mechanisms calibrated to millisecond injection profiles, where uniform silicone oil viscosity directly controls drug delivery duration.
Technical Consideration: For biologic formulations susceptible to silicone-induced aggregation, baked-on siliconization (cross-linking OH-terminated silicone fluid and hydrogen-terminated silicone fluid with silane catalysts onto glass walls at 300°C) reduces extractable sub-visible particles (SVP) by up to 90% compared to free liquid siliconization.
Penetration pain during cutaneous, subcutaneous, and intramuscular injections is primarily caused by shearing friction between the stainless steel needle cannula and the dermal micro-layers. Medical needle siliconization involves micro-spraying or dip-coating the needle bevel with an ultra-thin dispersion of PDMS silicone fluid or amino-modified silicone fluid (such as BY-209). The reactive amino groups anchor to the metal oxide surface while the polydimethylsiloxane chains orient outward, yielding a durable dry-lubricating monolayer.
Standardized puncture testing demonstrates a 60% to 75% reduction in needle entry force through skin simulant membranes, minimizing tissue tearing, bruising, and patient needle-phobia across mass vaccination campaigns and diabetic blood glucose lancets.
Vascular access devices, including peripheral IV catheters, central venous lines, and coronary guide wires, encounter severe frictional resistance during vessel cannulation and tortuous anatomical navigation. Polydimethylsiloxane fluid coatings prevent catheter kink, stop the outer polyurethane/PTFE tube from adhering to the internal stainless steel introducing needle, and reduce thrombogenic adhesion during initial blood contact.
In robotic-assisted minimally invasive surgery (MIS), mechanical precision is measured in microns. Articulating joints, cable-pulley systems, trocar seal valves, and endoscopic optical channel gaskets require long-term boundary lubrication that will not evaporate in negative pressure or migrate onto optical lenses. High-viscosity PDMS silicone oil provides non-migrating dampening and lubricity, extending instrument reprocessing cycles under repeated autoclave conditions.
In high-speed pharmaceutical vial filling lines operating at speeds exceeding 400 vials per minute, uncoated rubber stoppers exhibit high surface tackiness, causing hopper bridging, feed rail jams, and machinery downtime. Tumbling or spraying closures with medical dimethicone emulsions imparts anti-blocking properties, optimizes feed bowl sorting, and guarantees an airtight hermetic seal against glass vial crimp necks without leaching harmful contaminants into lyophilized cakes or liquid drugs.
Different medical device designs require targeted viscosities and functional end-groups to optimize coating thickness, longevity, and shear resistance:
| Polymer Chemical Type | Standard Viscosity Range | Primary Application Target | Coating Mechanism | Sterilization Compatibility |
|---|---|---|---|---|
| Linear PDMS Dimethicone | 100 cSt – 12,500 cSt | PFS Barrels, Plungers, Syringe Gaskets | Liquid boundary lubrication / Micro-spray | EtO, Autoclave, Gamma, E-beam |
| BY-209 Amino-Modified Fluid | 500 cSt – 3,500 cSt | Needle Cannula, Cutting Edges, Lancets | Surface chelation to metallic oxides | EtO, Gamma radiation |
| OH-Hydroxy Terminated Fluid | 750 cSt – 20,000 cSt | Baked Siliconization, Glass Vials | Thermally cured condensation network | Steam Autoclave, Dry Heat, EtO |
| Hydrogen-Terminated / MH Fluid | 15 cSt – 200 cSt | Crosslinker for RTV / Addition Coatings | Platinum-catalyzed addition cure | EtO, Gamma, E-beam |
| Vinyl Silicone Fluid | 200 cSt – 10,000 cSt | Medical Grade LSR & Self-Lubricating Gaskets | Hydrosilylation addition crosslinking | Autoclave, Gamma, EtO |
The global regulatory landscape governing medical device coatings is advancing rapidly under European Medical Device Regulation (MDR 2017/745) and United States FDA 21 CFR Part 820 quality systems. The primary engineering focus is centering around three progressive fronts:
1. Minimizing Sub-Visible Particle (SVP) Migration: In therapeutic protein injectables, excessive free liquid silicone oil droplets can interact with labile biologic molecules, provoking protein conformational changes and potential immunogenicity. Forward-thinking pharmaceutical manufacturers are adopting crosslinked and immobilized silicone coatings, such as plasma-treated silicone grafting and photochemically immobilized PDMS films, preventing silicone droplet shedding into the liquid matrix while maintaining glide lubricity.
2. Tightened Cyclosiloxane Limits: In alignment with European REACH restrictions on Octamethylcyclotetrasiloxane (D4), Decamethylcyclopentasiloxane (D5), and Dodecamethylcyclohexasiloxane (D6), modern chemical synthesis routes utilize advanced vacuum molecular distillation to achieve ultra-pure silicone fluids with residual volatile cyclic species below 0.1% (w/w), establishing unprecedented safety profiles for long-term implantable components.
3. Advanced Curable Functional Dimethicones: The integration of vinyl-functional, hydride-terminated, and amino-functionalized siloxanes has unlocked solvent-free, UV-curable, and low-temperature thermal curing systems, reducing volatile organic compound (VOC) emissions across automated medical manufacturing plants worldwide.
Hangzhou Bayee Chemical Co., Ltd. started chemical products exporting from 2001, manufacturers based exporter focused in chemical products covering Silicone series, Phosphorus series including Silicone Monomers, Cyclosiloxane, Silicone Oils, Agro Chemicals, Fire Retardants & Auxiliaries etc. Company has direct Import & Export right, Dangerous Cargo Permission Certificate. Based on 20+ years exporting history and persistent improvements, we have now grown and developed into a well known & good reputation exporter with ISO 9001:2015, AAA Credit certified company, also granted by local government as Healthy Enterprise, and A level Tax Ranking.

Based on strategic factories in Zhejiang, Jiangsu, Shandong, Anhui, Jiangxi, Hubei, Hunan, Hebei and Henan provinces etc, we export not only good quality products, competitive EXW costs, but also honesty, safety and international philosophies to customers. We work tightly with competitive production sites across whole China, who have special advantages, located in professional industrial areas, close to raw material bases, locally supplied with energy - gas or steam pipe connected with neighbour enterprises in same areas to reduce transportation costs. Our factories have advanced ideas in technique crafts for higher yield production, unit consumption reducing from raw materials, also re-used the by-products for own downstream production for other products. By the way, we always keep close observation about raw material changing trend, react actively with factories shoulder by shoulder from organizing raw material at good times to secure more competitive production costs and share spaces with customers helping win their market shares. At the same time, we have wide connection with Chinese powerful chemical institute organizations for testing and supervising quality control in production process.
Up till now we’ve developed and supplied to many countries and areas all over the world, with main markets in European countries (Germany, Italy, UK, Spain, Ukraine, Russia, Poland, etc.), USA, South America, Mid East, South-east Asia, Australia, etc. Also seeking more strategic partners and customers under mutual benefits and work through the whole purchasing chain.
Select from our comprehensive portfolio of medical device grade fluids, reactive functional siloxanes, and specialty silicone oils.